In this brief, we discuss the introduction of interchangeable biosimilars, a generic form of biologics, as well as efforts to encourage their use, particularly in the Medicare program.
AIR has created a plain-language FAQ that addresses a variety of topics related to the COVID-19 pandemic. It is designed to make information accessible and comprehensible to everyone, regardless of education level or background.